Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print

Financial Report: BASi



Published May 11, 2012
Related Searches: Bioanalytical Financial Reports
BASi

2Q Revenues: $7.0 million (-17%)

2Q Loss: $1.9 million (Earnings were $483,000 2Q11)

YTD Revenues: $14.5 million (-12%)

YTD Loss: $3.4 million (Earnings were $793,000 YTD11)

Comments: Service revenue was $5.3 million (-18%). Product revenue was $1.7 million (-15%). Results include restructuring charges of $64,000. In addition to the restructuring of its bioanalytical lab operations, the company plans to reduce operating costs at its West Lafayette and Evansville facilities for a savings of approximately $2.5 million annually, as part of an effort to improve performance.  
 


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On